Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C24 - Pediatric Headache

Saturday 04/22/23
02:45 PM - 04:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Kenneth J. Mack, MD, PhD, FAAN
Child Neurology and Developmental Neurology, Headache
Participants should be able to apply a holistic approach to the treatment of children and adolescents with migraine that ranges from lifestyle factors, to appropriate acute therapies, to prevention; appraise recent studies of injection and neurostimulation therapies in child and adolescent migraine; and recognize the frequent co-morbidities in migraine, and understand how these co-morbid factors contribute to our patient's disease burden.
2.00 CME credits
Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Advanced Practice Provider
Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Didactic

Program Materials Program Evaluations

Event Timeline
02:45 PM - 02:45 PM EST Speaker Introduction
Kenneth J. Mack, MD, PhD, FAAN
02:45 PM - 03:25 PM EST Speaker Evaluation and Treatment of Pediatric Migraine
Hannah Shapiro, MD
03:25 PM - 04:05 PM EST Speaker Blocks, Botox, and Buzzers for Pediatric Headache
Christina Lynch Szperka, MD
04:05 PM - 04:45 PM EST Speaker Chronification and Co-Morbidities in Pediatric Headache
Kenneth J. Mack, MD, PhD, FAAN
Faculty Disclosures
Kenneth J. Mack, MD, PhD, FAAN Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVie. Dr. Mack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. Dr. Mack has received publishing royalties from a publication relating to health care.
Christina Lynch Szperka, MD The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.
Hannah Shapiro, MD Dr. Shapiro has nothing to disclose.